3696 — Insilico Medicine Cayman TopCo Balance Sheet
0.000.00%
Last trade - 00:00- HK$32.77bn
- HK$31.15bn
- $56.24m
Annual balance sheet for Insilico Medicine Cayman TopCo, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|
| Period Length: | — | — | — | — |
| Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | PRESS |
| Standards: | IFRS | IFRS | IFRS | — |
| Status: | Final | Final | Final | Final |
| Cash | ||||
| Short Term Investments | ||||
| Cash and Short Term Investments | 208 | 177 | 126 | 447 |
| Net Total Accounts Receivable | ||||
| Net Total Receivables | 6.32 | 4.91 | 4.69 | 27 |
| Prepaid Expenses | ||||
| Total Other Current Assets | ||||
| Total Current Assets | 219 | 189 | 133 | 474 |
| Gross Property, Plant And Equipment | ||||
| Accumulated Depreciation | ||||
| Net Property, Plant And Equipment | 14.3 | 12.8 | 9.44 | 13.2 |
| Net Intangible Assets | ||||
| Long Term Investments | ||||
| Other Long Term Assets | ||||
| Total Assets | 235 | 203 | 144 | 490 |
| Accounts Payable | ||||
| Payable / Accrued | ||||
| Accrued Expenses | ||||
| Notes Payable / Short Term Debt | ||||
| Current Portion of Long Term Debt / Capital Leases | ||||
| Total Other Current Liabilities | ||||
| Total Current Liabilities | 682 | 852 | 807 | 33.9 |
| Capital Lease Obligations | ||||
| Total Long Term Debt | ||||
| Total Debt | ||||
| Total Liabilities | 684 | 853 | 808 | 38 |
| Common Stock | ||||
| Additional Paid In Capital | ||||
| Retained Earnings (Accumulated Deficit) | ||||
| Treasury Stock | ||||
| Other Equity | ||||
| Total Equity | -450 | -650 | -664 | 452 |
| Total Liabilities & Shareholders' Equity | 235 | 203 | 144 | 490 |
| Total Common Shares Outstanding |